SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech fireworks -- Ignore unavailable to you. Want to Upgrade?


To: zeta1961 who wrote (2582)7/27/2006 4:11:09 PM
From: tuck  Respond to of 7424
 
BIOV -- Bioveris, or what's left of the old IGEN -- up 20% on getting a CRO to sell their stuff:

Message 22663106

There have also been rumors Roche Diagnostics is selling in Bioveris' field, just like it did with IGEN. If so, that'll get them into arbitration, and odds are it would be favorable to BIOV. But so far, I've heard only rumors, based on some language in their 10-K, I think.

Cheers, Tuck